COVID-19 Pandemic - Perspective through Unani Medicine

Farooqui, Shazia Parveen; Quamri, Mohd Aleemuddin; Basheer, Rukhsar; Baig, Sana; Ahmed, Khaleel; Ahad, Mariyam; Ansari, Fasihurrehman

doi:10.5455/jrtm.2020/67262

Cited by 2 publications

(3 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The results displayed that the extract (higher than a dosage of 0.5-4 mg/ml) has a significant result (p<0.05) in suspending growth, acid production, and insoluble glucan formation. Also, it decreases the compliance of S. mutan in the synthesis test of soluble glucan for 2-4 mg/ml significantly [37].…”

Section: Anti-virus/microbementioning

confidence: 96%

“…Saussurea lappa has a tremendous protective effect via its activity of anti-oxidant, so it can be a better candidate as a natural anti-oxidant to deal with the side effects of dangerous glucocorticoids [39]. Flavonoid and unani drug to Covid-19 has antioxidant [37]. The content of total phenolic and flavonoid from n-butanol fraction of S. lappa was 44.43 μg gallic acid equivalent to (GAE)/g extract and 92.15 μg quercetin equivalent to (QE)/g extract which were determined by the Folin-Ciocalteu colorimetric method and aluminum nitrate, respectively, were higher than other solvent fractionation.…”

Section: Anti-oxidantmentioning

confidence: 99%

“…8 [34] Anti-inflammation, Sesquiterpene effect isolated from Saussurea lappa in inhibiting TNF-α secretion, in which the main component is costunolide, showing activity of TNF-α inhibiting. 9 [37] Anti-inflammatory, immunomodulator, antidote, antiseptic, disinfectant expectorant Unani drug to Covid-19 has antioxidant, anti-virus, immunomodulator, anti-parasite effect, antiseptic, antidote, and expectorant. Saussurea lappa acts in pharmacologic activities, such as hepatoprotective, anti-inflammation, immunomodulator, antidote, antiseptic, disinfectant, and expectorant.…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Qust Al Hindi (Saussurea Lappa): A Narrative Review of Its Phytochemistry and Pharmacological Potential Against Covid-19

Musfiroh

Muchtaridi

et al. 2022

Int J App Pharm

View full text Add to dashboard Cite

In 2020, the World Health Organization officially designated Coronavirus Disease 2019 (COVID-19) to be global pandemic. Response of immune to SARS-CoV-2 infection includes a hyper-inflammatory state. Saussurea lappa is a medical plant known in several traditional medical systems, such as Persian and Indian medicine. S. lappa has anticancer, antiviral, antirheumatic, anti-inflammatory, and hepatoprotective properties as clinically demonstrated. The purpose of this article to analyze the content of chemical compounds and possible pharmacological activities to fight COVID-19. As primary data sources for this study, researchers looked at articles about the possibility of Saussurea lappa as an alternative in the treatment of COVID-19. Data were gathered online through various academic papers published from 2012 to 2022 derived from the PubMed and Google Scholar databases. One of the components of Saussurea lappa is myrcene which might act on ACE receptors. SARS-CoV-2 enters cells via endocytosis after binding to the ACE2 receptor. The anti-inflammatory properties of Saussurea lappa can be used to treat COVID-19 by reducing inflammatory cytokinins (TNF-α, IL-1β). Further study and clinical trials are needed to prove the effectiveness of Saussurea lappa against COVID-19 patients. Saussurea lappa has a important role in treating COVID-19 based on the effects of active phytochemical compounds that have anti-inflammatory activity, antioxidant, immunomodulator, antcancer, antihepatotoxic, and antihipertension. The Qust al Hindi has not yet been a final drug for the treatment of COVID-19 for it must go through clinical trials on COVID-19 patients directly.

show abstract

Section: Anti-virus/microbementioning

confidence: 96%

Section: Anti-oxidantmentioning

confidence: 99%